Influenza-induced Rhabdomyolysis after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma

DOI Web Site Web Site PubMed 参考文献18件
  • NOZOE Masatsugu
    Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences
  • IlNO Tadafumi
    Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences
  • NAGAFUJI Koji
    Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences
  • MIYAMOTO Toshihiro
    Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences
  • ITO Hiroyuki
    Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences
  • GONDO Hisashi
    Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences
  • HARADA Mine
    Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences

この論文をさがす

抄録

We report influenza-induced rhabodmyolysis and congestive heart failure after high-dose therapy and hematopoietic stem cell transplantation for malignant lymphoma. Four months after autologous peripheral blood stem cell transplantation for the treatment of malignant lymphoma, a 65-year-old Japanese man developed acute congestive heart failure requiring artificial ventilation and rahbdomyolysis. Since influenza A virus was documented from his nasal cavity, he was diagnosed as rhabdomyolysis and congestive heart failure induced by influenza A infection. Neuraminidase inhibitor (oseltamivir 150 mg/day for 5 days) was administrated, and heart failure and respiratory status were improved. Our experience suggests that early treatment with neuraminidase inhibitor may improve the clinical outcome of influenza-induced rhabdomyolysis and congestive heart failure.<br>(Internal Medicine 42: 1127-1130, 2003)

収録刊行物

  • Internal Medicine

    Internal Medicine 42 (11), 1127-1130, 2003

    一般社団法人 日本内科学会

参考文献 (18)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ